Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(2), P. 237 - 237
Published: Jan. 26, 2022
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
non-communicable
chronic
that
top-ranking
with
respect
to
mortality
and
morbidity
rates,
posing
an
enormous
burden
on
patients,
caregivers
societies
at
large
[...].
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Feb. 21, 2022
ABSTRACT
Chronic
obstructive
pulmonary
disease
(COPD),
whose
main
risk
factor
is
cigarette
smoking
(CS),
one
of
the
most
common
diseases
globally.
Many
COPD
patients
also
develop
hypertension
(PH),
a
severe
complication
that
leads
to
premature
death.
Evidence
suggests
reactive
oxygen
species
(ROS)
involvement
in
and
PH,
especially
regarding
artery
smooth
muscle
cells
(PASMC)
dysfunction.
However,
effects
CS
on
vasculature
are
not
completely
understood.
Herein
we
provide
evidence
extract
(CSE)
exposure
PASMC
ROS
production,
antioxidant
response
its
consequences
vascular
tone
dysregulation.
Our
results
indicate
CSE
promotes
mitochondrial
fission,
membrane
depolarization
increased
superoxide
levels.
increase
did
parallel
counterbalancing
human
(PA)
cells.
Interestingly,
chelator
mitoTEMPO
reduced
fission
potential
caused
by
CSE.
As
have
previously
shown,
reduces
PA
vasoconstriction
vasodilation.
In
this
respect,
prevented
impaired
nitric
oxide-mediated
vasodilation,
while
remained
reduced.
Finally,
observed
CSE-driven
downregulation
Cyb5R3
enzyme,
which
prevents
soluble
guanylyl
cyclase
oxidation
PASMC.
This
might
explain
CSE-mediated
decrease
These
there
be
connection
between
altered
vasodilation
responses
PH
secondary
COPD,
strongly
support
strategies
specifically
targeting
mitochondria
as
new
therapy
for
these
diseases.
Graphical
abstract
Organoid,
Journal Year:
2021,
Volume and Issue:
1, P. e12 - e12
Published: Nov. 15, 2021
Respiratory
medicine
has
high
barriers
to
new
drug
development,
with
fewer
approved
treatments
and
candidate
drugs
a
higher
failure
rate
than
other
common
disease
fields.
Most
of
the
major
identified
in
preclinical
animal
studies
fail
clinical
setting
because
differences
between
models
humans.
Therefore,
rapid
development
3-dimensional
(3D)
organoid-based
that
recapitulate
human
pathological
attracted
increasing
attention
personalized
medicine.
In
present
study,
we
generated
bronchoalveolar
organoids
(BAOs)
from
pluripotent
stem
cells
(hPSCs)
assessed
their
potential
as
pulmonary
model.
Derived
BAOs
contained
expected
spectrum
differentiated
cells,
including
alveolar
progenitors,
type
1
2
epithelial
basal
secretory
ciliated
mesenchymal
cells.
When
were
exposed
transforming
growth
factor-beta,
both
fibrosis-
inflammation-related
transcripts
significantly
upregulated
compared
control.
addition,
exposure
cigarette
smoking
extract
induced
increased
levels
nitric
oxide
dose-dependent
manner,
well
upregulating
oxidative
stress-related
pro-inflammatory
genes.
These
findings
suggest
hPSC-derived
could
be
promising
platform
for
modeling
fibrosis
chronic
obstructive
testing
efficacy.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(2), P. 237 - 237
Published: Jan. 26, 2022
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
non-communicable
chronic
that
top-ranking
with
respect
to
mortality
and
morbidity
rates,
posing
an
enormous
burden
on
patients,
caregivers
societies
at
large
[...].